Data from Inhibition of <i>MCL-1</i> and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers

<div>Abstract<p>The MAPK pathway can drive resistance in highly aggressive breast cancers. Our previous work showed that the MEK inhibitor (MEKi) AZD6244 (selumetinib) prevented lung metastasis in a breast cancer xenograft model. In clinical studies, MEKis as single agents have had only modest activity against solid tumors due to the onset of resistance. Using synthetic lethality siRNA screening, we identified myeloid cell leukemia-1 (<i>MCL-</i><i>1</i>) as a potential contributor to AZD6244 resistance. We hypothesized that <i>MCL-1</i> promotes MEKi resistance in highly aggressive breast cancers and that <i>MCL-</i><i>1</i> inhibition overcomes AZD6244 resistance. We established two AZD6244-resistant cell lines: MDA-MB-231-R (triple-negative breast cancer) and SUM149-R (triple-negative inflammatory breast cancer). These resistant cells were characterized with respect to different parameters, and a combination of an <i>MCL-</i><i>1</i> inhibitor (<i>MCL-</i><i>1</i>i) together with an MEKi was evaluated <i>in vitro</i> and <i>in vivo</i> to overcome the acquired resistance. Compared with their respective parental cells, MDA-MB-231-R and SUM149-R cells showed increased proliferation, colony formation, stemness, anchorage-independent growth, and <i>MCL-1</i> expression levels. <i>MCL-1</i> knockdown in resistant cells decreased cell proliferation and colony formation, increased apoptosis, and was associated with high expression of the proapoptotic proteins PUMA, NOXA, BAK, and BAX. MEKi resistance was overcome when resistant cells were treated with <i>MCL-1</i>i and MEKi combined. In an <i>in vivo</i> mouse model, inhibition of <i>MCL-1</i> restored sensitivity to AZD6244. Our results suggest that <i>MCL-1</i> is a driver of MEKi resistance and that combining an <i>MCL-1</i>i with an MEKi warrants further investigation in triple-negative and triple-negative inflammatory breast cancer.</p></div>